Literature DB >> 7141703

Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin.

J Holmgren, P Fredman, M Lindblad, A M Svennerholm, L Svennerholm.   

Abstract

The receptors for cholera toxin and Escherichia coli heat-labile toxin (LT) in rabbit small intestinal epithelium were characterized and compared. (i) In vivo studies in ligated intestinal loops showed that whereas LT B subunits could block the fluid secretogenic action of purified LT as well as cholera toxin, cholera toxin B subunits did not inhibit the LT response even when tested in a concentration 100-fold higher than one which gave complete blocking of cholera toxin action. (ii) In vitro studies indicated that isolated intestinal epithelial cells or brush-border membranes could bind about 10-fold more of E. coli LT than of cholera toxin. (iii) All binding sites for cholera toxin in duodenal, jejunal, or ileal mucosal cells or brush-border membranes were extracted by chloroform-methanol-water (4:8:3), which removed lipids quantitatively but did not extract glycoproteins. The extracted cholera toxin binding sites were to greater than 95% recovered in a monosialoganglioside fraction; quantitatively these sites closely corresponded to the concentration of chromatographically identified mucosal GM1 ganglioside (1 nmol of cholera toxin was bound per 1 to 2 nmol of GM1). In contrast, a substantial fraction of mucosal binding sites for E. coli LT remained in the delipidized tissue residue, and these sites had properties consistent with a glycoprotein nature. Thus, whereas cholera toxin appeared to bind highly selectively to GM1 ganglioside receptor sites of rabbit small intestine, E. coli LT bound both to GM1 ganglioside and to a main glycoprotein receptor for which cholera toxin lacks affinity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7141703      PMCID: PMC347756          DOI: 10.1128/iai.38.2.424-433.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Affinity chromatography and structural analysis of Vibrio cholerae enterotoxin-ganglioside agarose and the biological effects of ganglioside-containing soluble polymers.

Authors:  P Cuatrecasas; I Parikh; M D Hollenberg
Journal:  Biochemistry       Date:  1973-10-09       Impact factor: 3.162

2.  Gangliosides and membrane receptors for cholera toxin.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

3.  Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside.

Authors:  C A King; W E Van Heyningen
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Biosynthesis and biodegradation of rat brain gangliosides studied in vivo.

Authors:  M Holm; L Svennerholm
Journal:  J Neurochem       Date:  1972-03       Impact factor: 5.372

5.  Inhibition of the steroidogenic effects of cholera and heat-labile Escherichia coli enterotoxins by GM1 ganglioside: evidence for a similar receptor site for the two toxins.

Authors:  S T Donta; J P Viner
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli.

Authors:  N F Pierce
Journal:  J Exp Med       Date:  1973-04-01       Impact factor: 14.307

7.  Comparison of the action of Escherichia coli enterotoxin on the thymocyte adenylate cyclase-cyclic adenosine monophosphate system to that of cholera toxin and prostaglandin E1.

Authors:  T V Zenser; J F Metzger
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

8.  Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids.

Authors:  J Holmgren; I Lönnroth; L Svennerholm
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

9.  Quantitative isolation of total glycosphingolipids from animal cells.

Authors:  T Saito; S I Hakomori
Journal:  J Lipid Res       Date:  1971-03       Impact factor: 5.922

10.  Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid.

Authors:  J Holmgren
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

View more
  43 in total

1.  Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

Authors:  J Sanchez; J Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Intranasal immunogenicity and adjuvanticity of site-directed mutant derivatives of cholera toxin.

Authors:  G Douce; M Fontana; M Pizza; R Rappuoli; G Dougan
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.

Authors:  Frederik W van Ginkel; Raymond J Jackson; Naoto Yoshino; Yukari Hagiwara; Daniel J Metzger; Terry D Connell; Hong L Vu; Michael Martin; Kohtaro Fujihashi; Jerry R McGhee
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 4.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

5.  The sigma ligand, igmesine, inhibits cholera toxin and Escherichia coli enterotoxin induced jejunal secretion in the rat.

Authors:  J L Turvill; P Kasapidis; M J Farthing
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

6.  Role of 5-hydroxytryptamine type 3 receptors in rat intestinal fluid and electrolyte secretion induced by cholera and Escherichia coli enterotoxins.

Authors:  F H Mourad; L J O'Donnell; J A Dias; E Ogutu; E A Andre; J L Turvill; M J Farthing
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

7.  Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination).

Authors:  J Holmgren; A M Svennerholm; M Lindblad
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

8.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Ganglioside GM1 enzyme-linked immunospot assay for simple identification of heat-labile enterotoxin-producing Escherichia coli.

Authors:  C C Czerkinsky; A M Svennerholm
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

10.  Rapid GM1-enzyme-linked immunosorbent assay with visual reading for identification of Escherichia coli heat-labile enterotoxin.

Authors:  A M Svennerholm; G Wiklund
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.